We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Effect of Post-discharge Phone Calls on Patient Outcomes

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01580774
Recruitment Status : Completed
First Posted : April 19, 2012
Last Update Posted : August 29, 2017
Information provided by (Responsible Party):
Christine Soong, Mount Sinai Hospital, Canada

Brief Summary:
The purpose of this study is to determine whether a post-discharge telephone call to general medical patients discharged home will improve quality of care and adherence, and reduce hospital readmission.

Condition or disease

Detailed Description:
Currently, discharge from hospital in many institutions is a confusing process for patients filled with uncertainty and potential for harm. For instance, 1 in 5 discharges results in a post discharge adverse event, many of which are related to medication errors. These may lead to serious harm and possibly require readmission to hospital. Telephone follow-up calls after discharge has been studied in small single-center trials and as a part of a coordinated, multi-layered discharge process but its direct effectiveness is not known. Understanding the impact of this simple intervention on patient outcomes is an important step towards improving patients' discharge from hospital.

Study Type : Observational
Actual Enrollment : 334 participants
Observational Model: Case-Control
Time Perspective: Prospective
Official Title: Effect of Post-discharge Phone Calls on Patient Outcomes for General Internal Medicine Patients Discharged From a Teaching Hospital.
Study Start Date : July 2012
Primary Completion Date : March 2013
Study Completion Date : March 2013

Resource links provided by the National Library of Medicine

U.S. FDA Resources

Post-discharge phone call
All patients in this group will receive a phone call within 72-hours of being discharged from hospital.
Usual care (no phone call)

Primary Outcome Measures :
  1. Care Transition Measure-3 score (CTM-3) [ Time Frame: 30-days post discharge ]

Secondary Outcome Measures :
  1. Hospital readmission [ Time Frame: 30-day post discharge ]
  2. Emergency department visit [ Time Frame: 30-days post discharge ]
  3. Patient satisfaction [ Time Frame: 30-days post discharge ]
  4. Treatment plan adherence [ Time Frame: 30-days post discharge ]
  5. Outpatient provider follow-up rates [ Time Frame: 30-days post discharge ]

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population
Study population is patients admitted to a general internal medicine ward.

Inclusion Criteria:

  • Admission to internal medicine ward
  • Discharged to home
  • Must have telephone access

Exclusion Criteria:

  • Discharged to care facility
  • Lack of telephone access

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01580774

Canada, Ontario
Mount Sinai Hospital
Toronto, Ontario, Canada, M5G 1X5
Sponsors and Collaborators
Mount Sinai Hospital, Canada
Principal Investigator: Christine Soong, MD Mount Sinai Hospital, New York

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Responsible Party: Christine Soong, Assistant Professor, Mount Sinai Hospital, Canada
ClinicalTrials.gov Identifier: NCT01580774     History of Changes
Other Study ID Numbers: MSHCANADA-CSCB
First Posted: April 19, 2012    Key Record Dates
Last Update Posted: August 29, 2017
Last Verified: August 2017